Literature DB >> 17091274

The occurrence of obstructive vs absorptive hydrocephalus in newborns and infants: relevance to treatment choices.

Liana Beni-Adani1, Naresh Biani, Liat Ben-Sirah, Shlomi Constantini.   

Abstract

BACKGROUND AND
OBJECTIVE: The classification of hydrocephalus in newborns and in infants is different from the classification in adulthood. This difference exists due to disparity in the source pathologies that produce the hydrocephalus, and the practical distinctions in prognosis and treatment choices. The objective of this paper is to present the spectrum of obstructive-communicating hydrocephalus, which is more complex in the pediatric group, and to propose the relevance of this particular classification to treatment options.
MATERIALS AND METHODS: The authors categorized infants with active hydrocephalus at time of presentation into the following four groups along the spectrum of communicating vs obstructive HCP. Group 1: patients with a purely absorptive (communicating) HCP. In these patients, tetraventricular dilatation is usually observed with occasional extraaxial fluid accumulation. An extracranial CSF diversion (shunt) is the treatment of choice. Group 2: patients with an obstructive component together with a persistent absorptive component. In these patients, a technically successful endoscopic procedure will not prevent progression of clinical symptoms of HCP. An extracranial CSF diversion (shunt) should be the treatment of choice even though some of these patients are currently treated by endoscopy. Group 3: patients with an obstructive component together with a temporary absorptive component. In these patients, a technically successful ETV should be followed by temporary CSF drainage [via LP, continuous spinal drainage (CLD), or ventriculostomy] with or without supplemental medical treatment (i.e., Diamox) for several days. Such temporary drainage may decrease failure rate in this subgroup. Group 4: patients with a purely obstructive HCP. In these patients, an endoscopic procedure (ETV) is the treatment of choice. According to this spectrum classification, the authors classify different entities with representative cases and discuss relevancy to treatment options and prognosis.
RESULTS: The data suggest that obstructive hydrocephalus in the very young population may be rather a combination of obstructive and absorptive problem. The outcome of the patient depends mainly not only on the basic pathology causing the hydrocephalus but also on the treatment that is chosen and its complications. While bleeding and infection represent the major causes for communicating hydrocephalus, patients with complex pathologies of congenital type and intra- or interventricular obstructions may reflect obstructive hydrocephalus. Treatment of these patients may be successful by shuntless procedures if the absorptive problem is not the major component. In transient absorptive hydrocephalus, temporary measures were effective in many cases leading to successful procedures of ETV and/or posterior-fossa decompression in selected cases.
CONCLUSIONS: Shuntless procedures are the dream of a pediatric neurosurgeon provided it solves the problem and does not imply unacceptable risk. However, the benefit has to be evaluated years after the procedure is performed, as only prospective multicenter studies will truly show which procedure may have the best overall results in the developing child. Until such studies are available, understanding the basic pathology or the combination of pathologies leading to hydrocephalus in a given child may open the window of opportunities for other than shunt surgery in many hydrocephalic children with major obstructive component.

Entities:  

Mesh:

Year:  2006        PMID: 17091274     DOI: 10.1007/s00381-006-0193-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  83 in total

1.  Neuroimaging findings in neonates and infants from superior vena cava obstruction after cardiac operation.

Authors:  Boaz Karmazyn; Ovdi Dagan; Bernado A Vidne; Gadi Horev; Liora Kornreich
Journal:  Pediatr Radiol       Date:  2002-07-12

2.  Failed endoscopic third ventriculostomy in children: management options.

Authors:  Aaron Mohanty; M K Vasudev; S Sampath; S Radhesh; V R Sastry Kolluri
Journal:  Pediatr Neurosurg       Date:  2002-12       Impact factor: 1.162

3.  Repeat endoscopic third ventriculostomy: is it worth trying?

Authors:  V Siomin; H Weiner; J Wisoff; G Cinalli; A Pierre-Kahn; C Saint-Rose; R Abbott; H Elran; L Beni-Adani; G Ouaknine; S Constantini
Journal:  Childs Nerv Syst       Date:  2001-09       Impact factor: 1.475

Review 4.  Alternatives to shunting.

Authors:  G Cinalli
Journal:  Childs Nerv Syst       Date:  1999-11       Impact factor: 1.475

5.  Endoscopic aqueductoplasty in the treatment of aqueductal stenosis.

Authors:  Henry W S Schroeder; Joachim Oertel; Michael R Gaab
Journal:  Childs Nerv Syst       Date:  2004-07-08       Impact factor: 1.475

Review 6.  Hydrocephalus in children: neurosurgical and neuroimaging concerns.

Authors:  J C Boaz; M K Edwards-Brown
Journal:  Neuroimaging Clin N Am       Date:  1999-02       Impact factor: 2.264

7.  Endoscopic third ventriculostomy.

Authors:  R F Jones; W A Stening; M Brydon
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

8.  Endoscopic third ventriculostomy in children younger than 1 year of age.

Authors:  Rodrigo Panico Gorayeb; Sergio Cavalheiro; Samuel Tau Zymberg
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

Review 9.  Selecting patients for endoscopic third ventriculostomy.

Authors:  Harold L Rekate
Journal:  Neurosurg Clin N Am       Date:  2004-01       Impact factor: 2.509

Review 10.  Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus.

Authors:  Michelangelo Gangemi; Francesco Maiuri; Simona Buonamassa; Giuseppe Colella; Enrico de Divitiis
Journal:  Neurosurgery       Date:  2004-07       Impact factor: 4.654

View more
  12 in total

1.  On the changing epidemiology of hydrocephalus.

Authors:  Luca Massimi; Giovanna Paternoster; Teresa Fasano; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-02-24       Impact factor: 1.475

2.  Cyclophosphamide-induced agenesis of cerebral aqueduct resulting in hydrocephalus in mice.

Authors:  Gajendra Singh; Sukh Mahendra Singh
Journal:  Neurosurg Rev       Date:  2007-04-25       Impact factor: 3.042

3.  Disruption of wave-associated Rac GTPase-activating protein (Wrp) leads to abnormal adult neural progenitor migration associated with hydrocephalus.

Authors:  Il Hwan Kim; Benjamin R Carlson; Clifford C Heindel; Hyun Kim; Scott H Soderling
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

Review 4.  MR assessment of pediatric hydrocephalus: a road map.

Authors:  Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

5.  The definition and classification of hydrocephalus: a personal recommendation to stimulate debate.

Authors:  Harold L Rekate
Journal:  Cerebrospinal Fluid Res       Date:  2008-01-22

6.  [Hydrocephalus in childhood : causes and imaging patterns].

Authors:  A Pomschar; I Koerte; A Peraud; F Heinen; S Herber-Jonat; M Reiser; B Ertl-Wagner
Journal:  Radiologe       Date:  2012-09       Impact factor: 0.635

7.  Pemetrexed and communicating hydrocephalus.

Authors:  Chang O Son; Frank E Mott
Journal:  Ochsner J       Date:  2014

Review 8.  Benign external hydrocephalus: a review, with emphasis on management.

Authors:  Sverre Morten Zahl; Arild Egge; Eirik Helseth; Knut Wester
Journal:  Neurosurg Rev       Date:  2011-06-07       Impact factor: 3.042

Review 9.  A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics.

Authors:  Harold L Rekate
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

10.  Complex hydrocephalus (combination of communicating and obstructive type): an important cause of failed endoscopic third ventriculostomy.

Authors:  Yad Ram Yadav; Gaurav Mukerji; Vijay Parihar; Mallika Sinha; Sanjay Pandey
Journal:  BMC Res Notes       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.